Here’s the press release
Microdose, the global leader in B2B psychedelic intelligence, is proud to be releasing The Psychedelic Industry Report & Online Directory: the most comprehensive investor focused report, tailored for the emerging psychedelic medicine space. This 500+ page investment grade market intelligence guide with 10k+ industry data points covers key insights, market data, sector fundamentals, transactions, clinical trials and important research in the psychedelic medicine space. Additionally, the Microdose website will feature a comprehensive online industry directory covering every player in the global market. This will all be promoted to a vast network of investors, including institutions, family offices, high net worths and retail. We help investors connect with leading companies, establishing a growing capital pool and a reputation for making deals and green lighting innovative projects. To gain the deepest insights into this rapidly emerging market and access it’s most valuable players, check out our psychedelic industry report and online directory today.
Psychedelic Medicine is Poised to Revolutionize Modern Medicine in a Massive Way
Before adoption by the “hippie” counterculture and their ultimate prohibition, psychedelic medicines were already being discovered to be radically effective in the treatment of mental illness and addiction by the medical community. The modern revival of psychedelic research is rapidly expanding on this early knowledge base and is poised to revolutionize healthcare as we know it. While the medical cannabis movement has helped establish regulatory framework and shift public perception about psychoactive drugs, psychedelic medicine is backed by much stronger peer-reviewed clinical data and garnered far more investor interest. From novel drug development strategies to unique psychedelic-medicine assisted treatment models, our report will give you the latest evidence-based information on the burgeoning psychedelic medicine industry.
By reading this report, you’ll learn about:
- Key psychedelic substances
- The emerging psychedelic capital markets from top experts and companies impacting the industry.
- The future of psychedelic derivatives and patentability in this space
- The therapeutic, spiritual, and performance-enhancing power of psychedelics
- The current research landscape, including drug safety, efficacy and the latest groundbreaking clinical trials
- VC funds and early investors
- IPOs and the global market
- The legal status of psychedelics around the world
- Exciting forewords from Robin Carhart-Harris, Rick Doblin, and Dennis McKenna.
“The mainstream acceptance of psychedelic medicine hinges on our ability to communicate their risks and benefits in a responsible and truthful manner. We are proud to be publishing this industry report that has been months in the making, with a special thank you to the team of contributors that worked tirelessly to create this incredibly comprehensive industry report, which we believe to be one of the most comprehensive global psychedelic industry reports available today.”
Patrick Moher – Microdose CEO
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
